UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma

Annals of hematology, 2020-12, Vol.99 (12), p.2869-2880

2020

Volltextzugriff (PDF)

Choline PET/CT in Multiple Myeloma

Cancers, 2020-05, Vol.12 (6), p.1394

2020

Volltextzugriff (PDF)

Prospective Comparison of 18-FDG PET/CT and Whole-Body MRI with Diffusion-Weighted Imaging in the Evaluation of Treatment Response of Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplant

Cancers, 2021-04, Vol.13 (8), p.1938

2021

Volltextzugriff (PDF)

Incidences of Deep Molecular Responses and Treatment-Free Remission in de Novo CP-CML Patients

Cancers, 2020-09, Vol.12 (9), p.2521

2020

Volltextzugriff (PDF)

Clinical and biological characterization of patients with low (0.1-2%) JAK2V617F allele burden at diagnosis

Haematologica (Roma), 2014-07, Vol.99 (7), p.e98

2014

Volltextzugriff (PDF)

Incidence and outcome of BCR‐ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitors

Cancer medicine (Malden, MA), 2019-09, Vol.8 (11), p.5173-5182

2019

Volltextzugriff (PDF)

Missense SLC25A38 variations play an important role in autosomal recessive inherited sideroblastic anemia

Haematologica (Roma), 2011-06, Vol.96 (6), p.808-813

2011

Volltextzugriff (PDF)

Relevance of treatment‐free remission recommendations in chronic phase chronic leukemia patients treated with frontline tyrosine kinase inhibitors

Cancer medicine (Malden, MA), 2021-06, Vol.10 (11), p.3635-3645

2021

Volltextzugriff (PDF)

Identification of methylguanine methyltransferase polymorphisms as genetic markers of individual susceptibility to therapy-related myeloid neoplasms

European journal of cancer (1990), 2014-01, Vol.50 (2), p.418-424

2014

Volltextzugriff (PDF)

Nilotinib efficacy, safety, adherence and impact on quality of life in newly diagnosed patients with chronic myeloid leukaemia in chronic phase: a prospective observational study in daily clinical practice

British journal of haematology, 2019-12, Vol.187 (5), p.615-626

2019

Volltextzugriff (PDF)

Vinblastine for elderly and frail patients with Hodgkin lymphoma

Leukemia & lymphoma, 2020-11, Vol.61 (13), p.3239-3242

2020

Volltextzugriff (PDF)

18F-FDG PET/CT and MRI in the Management of Multiple Myeloma: A Comparative Review

Frontiers in nuclear medicine, 2022-02, Vol.1

2022

Volltextzugriff (PDF)

Relevance of treatment‐free remission recommendations in chronic phase chronic leukemia patients treated with frontline tyrosine kinase inhibitors

Cancer medicine (Malden, MA), 2021-06, Vol.10 (11), p.3635-3645

2021

Volltextzugriff (PDF)

Outcome of patients with multiple myeloma (MM) relapsing after front-line autologous stem cell transplantation (ASCT): Impact of reduced intensity allogeneic transplantation (RICALLO)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e19564-e19564

2014

Volltextzugriff (PDF)

Identification Of MGMT Polymorphisms As Genetic Markers Of Individual Susceptibility To Therapy-Related Myeloid Neoplasms

Blood, 2013-11, Vol.122 (21), p.1545-1545

2013

Volltextzugriff (PDF)

ELN 2013 Response Status Criteria: Relevance For De Novo imatinib Chronic Phase Chronic Myeloid Leukemia Patients?

Blood, 2013-11, Vol.122 (21), p.4029-4029

2013

Volltextzugriff (PDF)

Impact Of Female Donor On Allogeneic Stem Cell Transplantation Outcome Of Male Recipient After T-Cell Depletion By Rabbit Antithymocyte Globulin

Blood, 2013-11, Vol.122 (21), p.5477-5477

2013

Volltextzugriff (PDF)

Risk Factors For Steroid-Refractory Acute Graft-Versus-Host Disease After Allogeneic Stem Cell Transplantation From Matched Related Or Unrelated Donors

Blood, 2013-11, Vol.122 (21), p.4595-4595

2013

Volltextzugriff (PDF)

ELN 2013 response status criteria: Relevance for de novo imatinib chronic phase chronic myeloid leukemia patients?

American journal of hematology, 2015-01, Vol.90 (1), p.37-41

2015

Volltextzugriff (PDF)

Improved Outcome After Allogeneic Stem-Cell Transplantation (SCT) As Compared to Non-Allogeneic SCT Therapies in Patients with High-Risk Peripheral T-Cell Lymphomas in First Response

Blood, 2012-11, Vol.120 (21), p.3111-3111

2012

Volltextzugriff (PDF)

Allograft After Pediatric-Inspired Therapy Does Not Improve Young patient's Outcome with High Risk Philadelphia- Chromosome-Negative Acute Lymphoblastic Leukemia (Ph-ALL). A Single Center Report

Blood, 2010-11, Vol.116 (21), p.3528-3528

2010

Volltextzugriff (PDF)

Viral Infection After Unrelated Cord Blood Transplantation In Bordeaux: Incidence and Outcomes. A Single Centre Experience with Eurocord

Blood, 2010-11, Vol.116 (21), p.4543-4543

2010

Volltextzugriff (PDF)

Ciclosporine and Metotrexate Reduce the Risk of High Grade Acute Gvhd after Busulfan, Fludarabine and Anti-Thymocyte Globulin conditioning Regimen in Comparison with Cyclosporine Alone

Blood, 2008-11, Vol.112 (11), p.4331-4331

2008

Volltextzugriff (PDF)

Risk Factors for Steroid-Refractory Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation from Matched Related or Unrelated Donors

Biology of blood and marrow transplantation, 2015-05, Vol.21 (5), p.860-865

2015

Volltextzugriff (PDF)

Potent Graft-versus-Leukemia Effect after Reduced-Intensity Allogeneic SCT for Intermediate-Risk AML with FLT3- ITD or Wild-Type NPM1 and CEBPA without FLT3- ITD

Biology of blood and marrow transplantation, 2012-12, Vol.18 (12), p.1845-1850

2012

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(13)
Science & Technology
(13)
Humans
(11)
Aged
(9)
Adult
(8)
Female
(8)
Hematology
(8)
Male
(8)
Middle Aged
(8)
Oncology
(8)
Aged, 80 And Over
(5)
Life Sciences
(5)
Young Adult
(5)
Chronic Myeloid Leukemia
(4)
Leukemia
(4)
Patients
(4)
Cancer
(3)
Hematology, Oncology And Palliative Medicine
(3)
Imatinib
(3)
Kinases
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma

Choline PET/CT in Multiple Myeloma

Prospective Comparison of 18-FDG PET/CT and Whole-Body MRI with Diffusion-Weighted Imaging in the Evaluation of Treatment Response of Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplant

Incidences of Deep Molecular Responses and Treatment-Free Remission in de Novo CP-CML Patients

Clinical and biological characterization of patients with low (0.1-2%) JAK2V617F allele burden at diagnosis

Incidence and outcome of BCR‐ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitors

Missense SLC25A38 variations play an important role in autosomal recessive inherited sideroblastic anemia

Relevance of treatment‐free remission recommendations in chronic phase chronic leukemia patients treated with frontline tyrosine kinase inhibitors

Identification of methylguanine methyltransferase polymorphisms as genetic markers of individual susceptibility to therapy-related myeloid neoplasms

Nilotinib efficacy, safety, adherence and impact on quality of life in newly diagnosed patients with chronic myeloid leukaemia in chronic phase: a prospective observational study in daily clinical practice

Vinblastine for elderly and frail patients with Hodgkin lymphoma

18F-FDG PET/CT and MRI in the Management of Multiple Myeloma: A Comparative Review

Relevance of treatment‐free remission recommendations in chronic phase chronic leukemia patients treated with frontline tyrosine kinase inhibitors

Outcome of patients with multiple myeloma (MM) relapsing after front-line autologous stem cell transplantation (ASCT): Impact of reduced intensity allogeneic transplantation (RICALLO)

Identification Of MGMT Polymorphisms As Genetic Markers Of Individual Susceptibility To Therapy-Related Myeloid Neoplasms

ELN 2013 Response Status Criteria: Relevance For De Novo imatinib Chronic Phase Chronic Myeloid Leukemia Patients?

Impact Of Female Donor On Allogeneic Stem Cell Transplantation Outcome Of Male Recipient After T-Cell Depletion By Rabbit Antithymocyte Globulin

Risk Factors For Steroid-Refractory Acute Graft-Versus-Host Disease After Allogeneic Stem Cell Transplantation From Matched Related Or Unrelated Donors

ELN 2013 response status criteria: Relevance for de novo imatinib chronic phase chronic myeloid leukemia patients?

Improved Outcome After Allogeneic Stem-Cell Transplantation (SCT) As Compared to Non-Allogeneic SCT Therapies in Patients with High-Risk Peripheral T-Cell Lymphomas in First Response

Allograft After Pediatric-Inspired Therapy Does Not Improve Young patient's Outcome with High Risk Philadelphia- Chromosome-Negative Acute Lymphoblastic Leukemia (Ph-ALL). A Single Center Report

Viral Infection After Unrelated Cord Blood Transplantation In Bordeaux: Incidence and Outcomes. A Single Centre Experience with Eurocord

Ciclosporine and Metotrexate Reduce the Risk of High Grade Acute Gvhd after Busulfan, Fludarabine and Anti-Thymocyte Globulin conditioning Regimen in Comparison with Cyclosporine Alone

Risk Factors for Steroid-Refractory Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation from Matched Related or Unrelated Donors

Potent Graft-versus-Leukemia Effect after Reduced-Intensity Allogeneic SCT for Intermediate-Risk AML with FLT3- ITD or Wild-Type NPM1 and CEBPA without FLT3- ITD

Suchergebnisse filtern